1. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443
2. Gherardi, E., Gray, J., Stoker, M., Perryman, M., and Furlong, R. (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U S A 86, 5844-5848
3. Weidner, C., Schmelz, M., Schmidt, R., Hansson, B., Handwerker, H. O., and Torebjork, H. E. (1999) Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci 19, 10184-10190
4. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. (1991) Identification of the hepatocyte growth factor receptor as the cmet proto-oncogene product. Science 251, 802-804
5. Trusolino, L., Bertotti, A., and Comoglio, P. M. (2010) MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11, 834-848
6. Borowiak, M., Garratt, A. N., Wustefeld, T., Strehle, M., Trautwein, C., and Birchmeier, C. (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 101, 10608-10613
7. Nakamura, T., Sakai, K., Nakamura, T., and Matsumoto, K. (2011) Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 26 Suppl 1, 188- 202
8. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., and Birchmeier, C. (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768-771
9. Matsumoto, K., Umitsu, M., De Silva, D. M., Roy, A., and Bottaro, D. P. (2017) Hepatocyte growth factor/MET in cancer progression and biomarker discovery. Cancer Sci 108, 296-307
10. Sierra, J. R., and Tsao, M. S. (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3, S21-35
11. Comoglio, P. M., Trusolino, L., and Boccaccio, C. (2018) Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer 18, 341-358
12. Kajiwara, K., Yamano, S., Aoki, K., Okuzaki, D., Matsumoto, K., and Okada, M. (2021) CDCP1 promotes compensatory renal growth by integrating Src and Met signaling. Life Sci Alliance 4
13. Ikeda, J., Oda, T., Inoue, M., Uekita, T., Sakai, R., Okumura, M., Aozasa, K., and Morii, E. (2009) Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 100, 429-433
14. Miyazawa, Y., Uekita, T., Hiraoka, N., Fujii, S., Kosuge, T., Kanai, Y., Nojima, Y., and Sakai, R. (2010) CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 70, 5136- 5146
15. He, Y., Wu, A. C., Harrington, B. S., Davies, C. M., Wallace, S. J., Adams, M. N., Palmer, J. S., Roche, D. K., Hollier, B. G., Westbrook, T. F., Hamidi, H., Konecny, G. E., Winterhoff, B., Chetty, N. P., Crandon, A. J., Oliveira, N. B., Shannon, C. M., Tinker, A. V., Gilks, C. B., Coward, J. I., Lumley, J. W., Perrin, L. C., Armes, J. E., and Hooper, J. D. (2016) Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance. Oncogene 35, 468- 478
16. Turdo, F., Bianchi, F., Gasparini, P., Sandri, M., Sasso, M., De Cecco, L., Forte, L., Casalini, P., Aiello, P., Sfondrini, L., Agresti, R., Carcangiu, M. L., Plantamura, I., Sozzi, G., Tagliabue, E., and Campiglio, M. (2016) CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers. Oncotarget 7, 69649-69665
17. Liu, H., Ong, S. E., Badu-Nkansah, K., Schindler, J., White, F. M., and Hynes, R. O. (2011) CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci U S A 108, 1379-1384
18. Uekita, T., and Sakai, R. (2011) Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci 102, 1943-1948
19. Wright, H. J., Arulmoli, J., Motazedi, M., Nelson, L. J., Heinemann, F. S., Flanagan, L. A., and Razorenova, O. V. (2016) CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer. Oncogene 35, 4762-4772
20. Leroy, C., Shen, Q., Strande, V., Meyer, R., McLaughlin, M. E., Lezan, E., Bentires-Alj, M., Voshol, H., Bonenfant, D., and Alex Gaither, L. (2015) CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases. Oncogene 34, 5593-5598
21. Trusolino, L., Cavassa, S., Angelini, P., Ando, M., Bertotti, A., Comoglio, P. M., and Boccaccio, C. (2000) HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 14, 1629-1640
22. Michiels, F., Habets, G. G., Stam, J. C., van der Kammen, R. A., and Collard, J. G. (1995) A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 375, 338-340
23. Koh, C. G., Manser, E., Zhao, Z. S., Ng, C. P., and Lim, L. (2001) Beta1PIX, the PAKinteracting exchange factor, requires localization via a coiled-coil region to promote microvillus-like structures and membrane ruffles. J Cell Sci 114, 4239-4251
24. Tamas, P., Solti, Z., Bauer, P., Illes, A., Sipeki, S., Bauer, A., Farago, A., Downward, J., and Buday, L. (2003) Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278, 5163-5171
25. Huveneers, S., and Danen, E. H. (2009) Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci 122, 1059-1069
26. Sanematsu, F., Nishikimi, A., Watanabe, M., Hongu, T., Tanaka, Y., Kanaho, Y., Cote, J. F., and Fukui, Y. (2013) Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle formation. J Biol Chem 288, 8092-8100
27. Feng, Q., Baird, D., Peng, X., Wang, J., Ly, T., Guan, J. L., and Cerione, R. A. (2006) Cool-1 functions as an essential regulatory node for EGF receptor- and Src-mediated cell growth. Nat Cell Biol 8, 945-956
28. Kojima, T., Fukuda, M., Watanabe, Y., Hamazato, F., and Mikoshiba, K. (1997) Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun 236, 333-339
29. Varnai, P., Rother, K. I., and Balla, T. (1999) Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J Biol Chem 274, 10983-10989
30. Rameh, L. E., Arvidsson, A., Carraway, K. L., 3rd, Couvillon, A. D., Rathbun, G., Crompton, A., VanRenterghem, B., Czech, M. P., Ravichandran, K. S., Burakoff, S. J., Wang, D. S., Chen, C. S., and Cantley, L. C. (1997) A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 272, 22059-22066
31. Clague, M. J. (2011) Met receptor: a moving target. Sci Signal 4, pe40
32. Arcaro, A., Aubert, M., Espinosa del Hierro, M. E., Khanzada, U. K., Angelidou, S., Tetley, T. D., Bittermann, A. G., Frame, M. C., and Seckl, M. J. (2007) Critical role for lipid raftassociated Src kinases in activation of PI3K-Akt signalling. Cell Signal 19, 1081-1092
33. Campa, F., Machuy, N., Klein, A., and Rudel, T. (2006) A new interaction between Abi-1 and betaPIX involved in PDGF-activated actin cytoskeleton reorganisation. Cell Res 16, 759-770
34. Heidary Arash, E., Song, K. M., Song, S., Shiban, A., and Attisano, L. (2014) Arhgef7 promotes activation of the Hippo pathway core kinase Lats. EMBO J 33, 2997-3011
35. Omelchenko, T., Rabadan, M. A., Hernandez-Martinez, R., Grego-Bessa, J., Anderson, K. V., and Hall, A. (2014) beta-Pix directs collective migration of anterior visceral endoderm cells in the early mouse embryo. Genes Dev 28, 2764-2777
36. Wang, H., Han, M., Whetsell, W., Jr., Wang, J., Rich, J., Hallahan, D., and Han, Z. (2014) Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma. Oncogene 33, 1558-1569
37. Hsu, Y. H., Lin, W. L., Hou, Y. T., Pu, Y. S., Shun, C. T., Chen, C. L., Wu, Y. Y., Chen, J. Y., Chen, T. H., and Jou, T. S. (2010) Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol 176, 3050-3061
38. Munoz-Bellvis, L., Fontanillo, C., Gonzalez-Gonzalez, M., Garcia, E., Iglesias, M., Esteban, C., Gutierrez, M. L., Abad, M. M., Bengoechea, O., De Las Rivas, J., Orfao, A., and Sayagues, J. M. (2012) Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays. Mod Pathol 25, 590-601
39. Goh, L. K., and Sorkin, A. (2013) Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol 5, a017459
40. Casar, B., Rimann, I., Kato, H., Shattil, S. J., Quigley, J. P., and Deryugina, E. I. (2014) In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated beta1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene 33, 255-268
41. Alajati, A., Guccini, I., Pinton, S., Garcia-Escudero, R., Bernasocchi, T., Sarti, M., Montani, E., Rinaldi, A., Montemurro, F., Catapano, C., Bertoni, F., and Alimonti, A. (2015) Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer. Cell Rep 11, 564-576